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Abstract
Background: Salmonella enterica serovar Typhi (S. Typhi) is strictly a human intracellular pathogen. It causes acute systemic
(typhoid fever) and chronic infections that result in long-term asymptomatic human carriage. S. Typhi displays diverse
disease manifestations in human infection and exhibits high clonality. The principal factors underlying the unique lifestyle of
S. Typhi in its human host during acute and chronic infections remain largely unknown and are therefore the main objective
of this study.
Methodology/Principal Findings: To obtain insight into the intracellular lifestyle of S. Typhi, a high-throughput phenotypic
microarray was employed to characterise the catabolic capacity of 190 carbon sources in S. Typhi strains. The success of this
study lies in the carefully selected library of S. Typhi strains, including strains from two geographically distinct areas
oftyphoid endemicity, an asymptomatic human carrier, clinical stools and blood samples and sewage-contaminated rivers.
An extremely low carbon catabolic capacity (27% of 190 carbon substrates) was observed among the strains. The carbon
catabolic profiles appeared to suggest that S. Typhi strains survived well on carbon subtrates that are found abundantly in
the human body but not in others. The strains could not utilise plant-associated carbon substrates. In addition, a-
glycerolphosphate, glycerol, L-serine, pyruvate and lactate served as better carbon sources to monosaccharides in the S.
Typhi strains tested.
Conclusion: The carbon catabolic profiles suggest that S. Typhi could survive and persist well in the nutrient depleted
metabolic niches in the human host but not in the environment outside of the host. These findings serve as caveats for
future studies to understand how carbon catabolism relates to the pathogenesis and transmission of this pathogen.
Citation: Chai LC, Kong BH, Elemfareji OI, Thong KL (2012) Variable Carbon Catabolism among Salmonella enterica Serovar Typhi Isolates. PLoS ONE 7(5): e36201.
doi:10.1371/journal.pone.0036201
Editor: Dipshikha Chakravortty, Indian Institute of Science, India
Received December 12, 2011; Accepted April 3, 2012; Published May 25, 2012
Copyright:  2012 Chai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by grant from University of Malaya UMC/HIR/MOHE/02 [A000002–50001]. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: thongkl@um.edu.my
Introduction
The Salmonella enterica serovar Typhi (S. Typhi) is an important
human intracellular pathogen of global importance, infecting as
many as 21.7 million people and killing 217,000 people annually
[1]. The pathogen causes typhoid fever in humans and is more
prevalent in less developed countries in South Central and
Southeast Asia with poor sanitation and unsafe water and food
supply [1]. The key risk factors of the disease include consumption
of contaminated water and food and contact with human carriers.
In Malaysia, healthy human carriers were detected in Kelantan,
which is a hotspot for typhoid fever in Malaysia [2]. S. Typhi is
rarely detected in water and food. Unlike other serovars of
Salmonella, which invade only the mucosal surface of the intestines,
S. Typhi has evolved the ability to spread to deeper tissues,
including the liver, spleen, bone marrow and gallbladder, in which
it persists, multiplies and disseminates in the urine and faeces [3].
S. Typhi is exclusively adapted to infect human host.
Despite the unique pathology and epidemiologic characteristics
of S. Typhi, it has received less attention globally as compared with
other Salmonella serovars, such as S. Typhimurium and S. En-
teritidis [4]. As the world continues to focus on many recent
findings concerning the pathogenic and adaptive mechanisms of
foodborne S. Typhimurium and S. Enteritidis, the principal factors
underlying the unique epidemiological pattern and disease
manifestation of this virulent, human-restricted, intracellular
pathogen, S. Typhi, remains intruiging. In recent years, increasing
evidence has implicated carbon catabolism as a virulence
determinant of human pathogens [5-7]. The ability of pathogenic
bacteria to metabolize various nutrients, especially carbon sources,
is essential for the invasion, growth, survival and colonisation in
intestinal and extra-intestinal sites in their hosts. To successfully
colonise and persist in the various niches within the host during the
course of infection, bacterial pathogens need to adjust and adapt
their metabolic activity to the local nutrient availability. None-
theless, as compared with the growing knowledge of molecular
bacterial virulence and pathogenesis, research on pathogenic
bacterial metabolism and persistence in the human host has
progressed very little [6].
S. Typhi exhibits unique characteristics as an intracellular
human pathogen that are not observed in other human bacterial
pathogens: it is human host restricted and incapable of infecting
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other living organisms; able to cause both acute and chronic
infection, displaying various disease manifestations; and able to
transform the human host into long-term asymptomatic carriage
in the environment with periodical dissemination via urine and
faeces. Therefore, it is important to understand the intracellular
lifestyle of this unique pathogen. To do so, we employed high-
throughput phenotypic microarray analysis to characterise the
carbon metabolic capacity of S. Typhi in the human host.
The novelty of this study is derived from the interesting and
diverse background of each of the S. Typhi strains included in this
work. These S. Typhi strains were carefully selected to include
strains from Malaysia and Chile to determine whether there were
any metabolic differences between the two areas of typhoid
endemicity which are distantly separated. To explore our
hypothesis that the metabolic capacity of the strains isolated from
stool develops an adaptive persistence mechanism in the liver or
gallbladder during chronic infection, these stool strains will differ
from the strains isolated from the blood during acute systemic
infection in the human host. A bacterial strain originated from a
healthy human carrier was included in this study to contrast with
the strains of transient chronic infection. The occurrence of S.
Typhi in the environment is extremely rare, even though it is
generally accepted that the pathogen could be transmitted via
contaminated water and foods. To examine whether transient
persistence in the sewage-contaminated water requires a special
metabolic capacity, we have included a strain isolated from
sewage-contaminated river in Chile during the 1983 Chilean
Typhoidal outbreak [8].
Results and Discussion
Phenotypic Characteristics
The eight unique S. Typhi strains studied in this work were
characterised into six pulsotypes based on pulsed-field gel
electrophoresis, which was performed previously in the laboratory
(unpublished data). Of these strains, ST191/05 and ST196/05,
both from the Kelantan outbreak in 2005, shared a similar
pulsotype. Similarly, strains ST5680/07, from another outbreak in
2007, and STC63/07 were isolated from a healthy human carrier
in the same locality, were and found to display identical
pulsotypes. This observation led to the speculation that the
chronic human carriage acts as the pathogen reservoir in this
hyperendemic state. However, the virulotyping of 22 virulence and
virulence-associated genes clearly distinguished the outbreak strain
ST5680/07 from the carrier strain, STC63/07, which was also
grouped together with ST33/06 (Table 1). Further analysis of
motility and carbon catabolism revealed divergent responses for
these two strains, therefore suggesting that ST5680/07 and
STC63/07 are two unique strains. However, strains ST191/05
and ST196/05 with similar pulsotype also shared similar
virulotypes, motility characteristic and carbon catabolic profiles.
Undoubtedly, ST191/05 and ST196/05 possibly originated from
the same ancestral strain.
Fimbrial genes are located in the chromosome and on the
plasmid. The agfA, agfC, lpfA, lpfC, sefC, and sefD and pefA genes
are important for adherence to different sites of the host cells; any
loss of these fimbrial genes will decrease the ability of Salmonella for
adherence in the host cells [9], [10]. The S. Typhi strains tested
lacked plasmids (data not shown); thus, it was not surprising that
the spvB and spvC, pefA, lpfA and lpfC genes, which are located on
the virulence plasmid, were absent. Nevertheless, variations
among the strains were observed in the aggregative fimbriae gene
(agfC), the SEF14 fimbriae genes (sefC and sefD) and the genes
involved in the intra-macrophage survivability (mgtC). The strains
ST190/07 and ST196/07, derived from the 2007 typhoid
outbreak, and strain STVC3121, derived from Chilean typhoid
outbreak, possessed 17 out of 22 virulence and virulence-
associated genes tested. The fimbriae genes, sefC and sefD, were
not detected in strains ST5680/07 and ST280/90. In addition,
mgtC gene was absent in strain ST280/90. The aggregative
fimbriae gene (agfC) was detected in all strains except the Chilean
environmental strain, STVC1681. The virulotype profiles are
shown in Table 1.
We have observed remarkably little motility in the carrier strain,
STC63/07, while strain ST5680/07 demonstrated rapid swarm-
ing on the agar surface (Table 1). The low motility rate was also
recorded in the Johor strain, ST280/90, which was isolated from
stool (Table 1). In fact, motility had been identified as a bacterial
virulence factor that aids in the gut colonisation to initiate
infection in the human host. The observation of a relatively
weaker motility capacity in the chronic carrier strain suggests that
motility might not be essential for the long-term persistence in the
human host. This postulation requires further investigation to
better understand the adaptive life style of S. Typhi within the
human host.
Limited Carbon Catabolism Capacity among S. Typhi
Strains
The carbon catabolism capacity of S. Typhi strains tested was
extremely low, recording only 21% to 27% of 190 carbon
substrates tested (Figure 1, Table S1). As compared with other
environmental bacteria and pathogens, such as S. Typhimurium
[11], Pseudomonas aeruginosa, and Burkholderia cepacia, that are able to
grow on more than 60 different types of carbon substrates, S.
Typhi was metabolically less versatile. Of these 27% (52 carbon
substrates) of utilisable carbon substrates, half (27 out of 52
substrates) were carbohydrates; 20% were carboxylic acids,
including amino acid, peptide and fatty acid; and 10% were
nucleosides (Table 2, Table S2). Almost all of the carbon substrates
utilisation by the strains is exclusively available in the gut, liver,
bile and blood of human host. Plant-derived carbon sources, such
as arbutin, gelatin, pectin, mannan, palatinose, xylitol and sorbic
acid, were not able to support growth in the S. Typhi strains tested.
The limited catabolic activity of the only carbon sources available
in the human host might be an evidence for the restricted infection
of S. Typhi to only human host and that the pathogen can hardly
persist in the environment outside of the host. While we expected
to observe a somewhat higher carbon catabolism in the only
environmental strain included in this study (STVC1681), the PM
profiling did not reveal a significantly wider range of carbon
source utilisation. Nonetheless, the carbon catabolic profile of this
environmental strain was unique, as shown in the PCA analysis
(Figure 2). The strain STVC1681 was isolated from the summer
typhoid outbreak in 1983 from the sewage contaminated
Mapocho River, Santiago, Chile [8], and was the only strain that
could respire on mucic acid. According to the classical work of
Sternfeld and Saunders [12], S. Enteritidis, and S. Schottmiilleri
utilised mucic acid for the production of acid; Aerobacter aerogenes
and S. aertrycke produced acid and gas; and Eberthella typhi (was
renamed as S. Typhi), Shigella dysenteriae, S. Choleraesuis, and S.
Paratyphi did not respire on mucic acid at all [13]. It is interesting
to further investigate whether the ability to utilise mucic acid
contributes to the survival S. Typhi outside of human host.
According to the classical study on carbon catabolism of S.
Typhimurium conducted by Gutnick and co-workers [11] in 1969,
S. Typhimurium, a less-specialised pathogen, could utilise 73
carbon sources tested. In comparison, almost all carbon sources
utilised by S. Typhi in this study were reported to be catabolised by
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S. Typhimurium LT-2, including mucic acid. However, not all
compounds used by S. Typhimurium (about 15 compounds) [11]
could serve as the sole carbon sources for S. Typhi. Perhaps, the
capability to catabolise a wider range of carbon sources is an
essential property for bacterial survival in a broader host range or
environment. Nonetheless, this hypothesis requires further inves-
tigation.
S. Typhi strain ST280/90 demonstrated extremely low carbon
metabolic activity. Virulotyping revealed ST280/90 as a variant
strain lacking mgtC gene. mgtC encodes for a 25-kDa protein of
unknown function. In S. Typhimurium [14] and S. Typhi [15], the
experimental evidence suggested that mgtC participates in the
adaptation to low-Mg2+ environments, supporting bacterial
invasion and proliferation in macrophages. MgtC is a virulence
factor that plays a vital role that is not supplied by any other
bacterial factor located in Salmonella Pathogenicity Island-3 (SPI-3)
[15]. The related studies have shown that the Salmonella mutant
lacking mgtC grew significantly less than the wild type at 10 mM of
MgCl2 whereas no difference was observed between the mutant
and wild type at 10 mM Mg2+ [15]. Therefore, we suspected that
the concentration of MgCl2 (50 mM) in the Biolog inoculating
fluid, IF-0 [16], might be too low to promote maximum growth of
the variant strain. To clarify the speculation, we cultivated the
variant strain, ST280/90, in M9 minimal media supplemented
with glucose and 10 mM, 50 mM and 100 mM of MgCl2. We
observed no growth in all the three MgCl2 concentrations tested
(data not shown). Despite its poor growth in most carbon sources,
we find it rather intriguing that ST280/90 showed comparable
growth as with the other seven strains in glycerol, a-methyl-D-
galactoside, 2-deoxyadenosine, adenosine and L-serine (Figure 1).
Further investigation is needed to find out how these carbon
sources compensate for the lack of mgtC gene, particularly the S.
Typhi strain.
S. Typhi Showed Active Respiration on Nucleosides, a-
glycerolphosphate, Glycerol, L-serine, Pyruvate and
Lactate
S. Typhi strains were able to uptake and metabolise most of
the monosaccharides tested, such as D-glucose, D-fructose, D-
galactose and D-glucose-1-phosphate. However, relative to the
respiration rate on nucleosides, a-glycerolphosphate, glycerol, L-
serine, pyruvate and lactate, monosaccharides supported only
moderate respiration in S. Typhi strains (Figure 1). It was not
surprising that nucleosides were rapidly catabolised by S. Typhi
strains, as numerous studies have reported that nucleosides are
excellent carbon sources in E. coli and Salmonella [17],[18]. We
believe that the active metabolism of nucleosides supports the
rapid proliferation of S. Typhi during invasive infection of the
bloodstream. Human blood serum is abundant in various
metabolites, including various amino acids and nucelosides
[19], [20]. The efficient uptake and catabolism of nucleosides
during the infection process provides sufficient substrates for
biosynthesis of nucleotide bases required for DNA synthesis and
repair of damaged DNA induced by the host’s reactive oxygen
intermediates during infection [21].
Alpha-glycerolphosphate and glycerol are abundant in the
liver and kidneys. In the human body, glycerol is rapidly
adsorbed in the intestines and stomach and distributed over the
extracellular space [22]. Glycerol is phosphorylated to a-
glycerophosphate by glycerol kinase, predominantly in the liver
(80–90%) and kidneys (10–20%) [22]. Glycerol, L-serine,
pyruvate and lactate serve as the substrate or end product of
gluconeogenesis and glycolysis, which also occurs predominantly
in the liver and to a lesser extend in the cortex of kidney.
Therefore, the observation of the relatively active metabolism of
these carbon sources was highly speculated to be associated to
adaptive mechanisms acquired by S. Typhi for the colonisation
and long-term persistence in the human host, specifically in the
liver, during chronic infection in the human host. The
availability of a-glycerophosphate, glycerol, L-serine, pyruvate
and lactate in the cortex of the kidney suggested the possible
transient colonisation of S. Typhi in human kidneys and causes
the dissemination of S. Typhi via urine. In fact, it has been
known for years that the typhoid human carriers disseminate
the pathogen through faeces and urine. This observation will be
investigated more in depth in a future study.
Distinct Carbon Catabolism Profile between Strains
Isolated from Human Stools and Blood
PCA analysis exhibited clearly distinct carbon catabolic activity
between the two clusters of S. Typhi strains: ST191/05, ST196/05
and ST33/06 as compared with ST5680/07, ST280/90 and
Table 1. Salmonella enterica serovar Typhi strains used in this study.
Strain Year Source Locality Pulsotype Virulotype* Motility
ST191/05 2005 Human (blood); outbreak Kelantan, Malaysia STXba003 V1 +++
ST196/05 2005 Human (blood); outbreak Kelantan, Malaysia STXba003 V1 +++
ST5680/07 2007 Human (stool); outbreak Kelantan, Malaysia STXba004 V3 +++
STC63/07 2007 Healthy human carrier (stool) Malaysia STXba004 V2 +
ST33/06 2006 Human (blood); outbreak Kelantan, Malaysia STXba005 V2 +++
ST280/90 1990 Human (stool);outbreak Johor, Malaysia STXba006 V4 ++
STVC1681 1983 Sewage contaminated water Chile STXba001 V5 +++
STVC3121 1983 Human (blood); outbreak Chile STXba002 V1 +++
*Virulence genes profiles among 8 S. Typhi strains tested.
(V) : agfA-agfC-cdtB-invA-iroN-lpfA-lpfC-mgtC-misL-orfL-pefA-pipD-prgH-sefC-sefD-sifA-sitC-sopB-sopE-spiC-spvB-spvC.
(V1): agfA-agfC-cdtB-invA-iroN- -mgtC-misL-orfL- -pipD-prgH-sefC-sefD-sifA-sitC-sopB-sopE-spiC-.
(V2): agfA-agfC-cdtB-invA-iroN- -mgtC-misL-orfL- -pipD-prgH-sefC- -sifA-sitC-sopB-sopE-spiC-.
(V3): agfA-agfC-cdtB-invA-iroN- -mgtC-misL-orfL- -pipD-prgH- -sifA-sitC-sopB-sopE-spiC-.
(V4): agfA-agfC-cdtB-invA-iroN- -misL-orfL- -pipD-prgH- -sifA-sitC-sopB-sopE-spiC-.
(V5): agfA- -cdtB-invA-iroN- -mgtC-misL-orfL- -pipD-prgH-sefC- -sifA-sitC-sopB-sopE-spiC-.
doi:10.1371/journal.pone.0036201.t001
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STC63/07 (P.0.05) (Table 3). The differences observed appeared
to be associated with the origin of the strains. The strains ST191/
05, ST196/05 and ST33/06 were all isolated from human
blood samples, sharing a similarity of 86.7% to 91.2% in their
carbon catabolic profile whereas the catabolic activity among
the strains obtained from stool samples (ST280/90, ST5680/07
and STC63/07) was more diverse, with a lower similarity level,
which ranged from 82.5% to 87.6%. Although the clinical
Chilean strain STVC3121 was also isolated from human blood,
it was catabolically unique from both clusters and from the
environmental Chilean strain (STVC1681). Notably, all the
three strains derived from the stool samples had a narrower
range in carbon utilisation and were comparatively weaker in
their catabolic activity (P,0.05; Table 3), specifically in the
catabolism of uridine and D-glucose-6-phosphate. The motility
test and growth in rich medium confirmed the findings
discussed above, as both analyses demonstrated lower motility
and delayed growth in S. Typhi strains from stools. The ability
to catabolise glucose-6-phosphate has been associated with the
intracellular survival and virulence of Salmonellae in mice [23].
This observation was indeed intriguing, as S. Typhi strains
isolated from stool and blood actually represented two different
stages in human infection and colonisation niches within the
human body. S. Typhi is able to invade the intestinal wall and
replicate within macrophages and infected phagocytes [24]. The
replication of the bacteria within macrophages in the liver and
spleen [25], [26] resulted in the release of the pathogen into the
bloodstream [27]. The pathogen later invades the gallbladder
and leads to bacterial shedding in the urine and faeces in the
chronic carriage of infected individuals [28], [29]. It is possible
that S. Typhi acquires different metabolic activity and pheno-
types for colonisation and persistence in these two different
niches, liver and spleen, which disseminate S. Typhi into the
blood stream and the gallbladder, which releases S. Typhi in the
urine and faeces. However, we could not entirely rule out the
possibility that the strains could be grouped simply by the
predominant strain in a given time and place. That is, the
strains from 2005 and 2006 from Kelantan could simply be
fortuitously similar whereas those strains isolated from 2007
would be similar; these strains would also be similar to those
isolated in 1990 and the Chilean strains would comprise their
own group. This grouping could be addressed through the study
of more strains, preferably from the same outbreak, isolated
both from blood and stools. A comprehensive study would
address the phenotypic differences in S. Typhi.
High Divergence in Carboxylic Acids Catabolism
Another notable finding in this study was the observation of
great divergence in the catabolism of amino acids, fatty acids and
other carboxylic acids. While less variation was recorded in the
Table 2. Catabolism of 190 carbon substrates by Salmonella enterica serovar Typhi strains.
Carbon substrate
*No. of carbon
substrates catabolised
by all strains
*No. of carbon
substrates
catabolised by at
least a strain
*No. of carbon
substrates not
catabolised
*No. of carbon
substrates tested
Sugars and derivatives Monosaccharide 9(45) 1(5) 10(50) 20
Disaccharide 2(22) 7(78) 9
Oligosaccharide 1(10) 9(90) 10
Polysaccharide 1(17) 5(83) 6
Sugar alcohol 4(22) 14(78) 18
Amino sugar 3(38) 5(63) 8
Deoxy sugar 4(100) 4
Aldaric acid 1(20) 4(80) 5
Aldonic acid 1(50) 1(50) 2
Uronic acid 3(38) 5(63) 8
Glycoside 1(11) 8(89) 9
Carboxylic acids and derivatives Monocarboxylic acid 1(11) 2(22) 6(67) 9
Dicarboxylic acid 11(100) 11
Tricarboxylic acid 1(33) 2(67) 3
Keto acid 1(11) 1(11) 7(78) 9
Fatty acid 1(14) 6(86) 7
Amino acid and peptide 5(15) 6(18) 22(67) 33
Amide 3(100) 3
Ketone 3(100) 3
Lactone and ester 2(40) 3(60) 5
Polysorbate surfactant 3(100) 3
Nucleic acid Nucleotide 5(100) 5
TOTAL 39(21) 13(7) 138(73) 190
*Number of substrate catabolised by all strains or some strains or not able to be catabolised by any strains (percentage of substrate catabolised by all strains or some
strains or not able to be catabolised by any strains).
doi:10.1371/journal.pone.0036201.t002
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metabolism of sugars, one strain of S. Typhi was unable to grow
on these six amino acids (L-proline, D-alanine, L-alanine, L-
glutamic acid, L-asparagine and L-threonine) and three short-
chain fatty acids (propionic acid, a-ketobutyric acid and a-
hydroxybutyric acid). The phenotypic microarray analyses
revealed that both the carrier (STC63/07) and the Johor strain
(ST280/90) lacked the catabolic pathways to uptake and
assimilate most of the amino acids and fatty acids stated above.
Studies have shown that the ability to catabolise amino acids in
Salmonella is essential for the virulence in mice [30–33]. In
addition, the catabolism of C2 substrates (e.g., fatty acids) plays a
crucial role in Salmonella metabolism in-vivo as the mutants of S.
Typhimurium that had lost their ability to grow on C2 substrates
are attenuated in mice [34]. The ability to metabolise on fatty
acids might also play a role in the early stages of infection, when
the bacteria reside within the lipid-rich mucus covering the
intestinal epithelium [35]. Metabolism of short chain fatty acids
might also be involved in the signaling required for expression of
virulence genes or the induced detoxification of these com-
pounds, which can have antimicrobial effects at high concentra-
tions [35–37]. Additional work is needed to determine how the
ability to catabolise carbon substrates relates to the virulence of
S. Typhi in-vivo.
Figure 1. Cluster analysis based on the carbon catabolism profile of the eight Salmonella enterica serovar Typhi strains. The
dendrogram and catabolic profiles show 52 active carbon substrates catabolised by the eight strains of S. Typhi tested. The cluster analysis was
performed with simple matching similarity based on the catabolic profile of 190 carbon substrates and the dendrogram was built with unweighted
paired group of arithmetic mean (UPGMA).
doi:10.1371/journal.pone.0036201.g001
Figure 2. Three-dimensional principle component analysis (PCA) of eight Salmonella enterica serovar Typhi strains. A three-
dimensional principle component analysis (PCA) of the eight S. Typhi strains was calculated from the corrected average area under the bacterial
growth curve. For each carbon well, the average area under the bacterial growth curve was corrected to zero if the Tmax–Tmin value was lesser than
the threshold value of 50.
doi:10.1371/journal.pone.0036201.g002
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Conclusion and Future Directions
In conclusion, the findings obtained in this study have revealed
interesting variations in the carbon catabolism among the S. Typhi
strains of a different background. The observation was indeed
astonishing, as carbon catabolism is one of the earliestmeans used by
the scientists to distinguish the bacteria, and is an essential property
of bacterial survival and persistence in its specific niches of habitat.
The diversity observed in the carbon catabolism profiles among this
set of diverse S. Typhi strains has suggested the possible involvement
of various metabolic pathways that might be related to the virulence
and pathogenesis of this host-restricted human pathogen. The
findings obtained in this study would serve as an important
foundation for future genomic and transcriptomic studies to
understand the relationship of carbon metabolism to the pathogen-
esis and transmission of this human-host-adapted pathogen. The
questions concerning the diversity of carbon catabolism provide
caveats for the future study of the pathogenicity of S. Typhi.
Materials and Methods
Media and Strains Used
Eight clinical strains of S. Typhi from our culture library were
selected for the present work (Table 1). All strains, except
STVC1681 and STVC3121 from the 1983 typhoid outbreak in
Chile [38] were of local origin. Four S. Typhi strains, namely
ST191/05, ST196/05, ST33/06 and ST5680/07, were isolated
during the typhoid outbreaks in the northeast state of Peninsular
Malaysia, Kelantan, which was a major typhoid hotspot from
2005 to 2007. The former two strains were isolated from blood
samples in 2005 and were genetically identical in terms of PFGE
subtyping; ST33/06 was isolated from a blood sample in 2006,
and ST5680/07 was isolated from a stool sample in 2007. In 2007,
a survey was performed in Kelantan to detect the presence of
potential typhoid carrier. Strain STC63/07 was isolated from the
stool sample of a healthy adult in Kelantan. The pulsotype of
STC63/07 was indistinguishable from strain ST5680/07, which
was isolated from the 2007 Kelantan typhoid outbreak (unpub-
lished data). S. Typhi strain ST280/90 originated from the stool
sample of a victim of another typhoid outbreak in Malaysia, Johor,
in 1990 and was also included in the study [38]. All S. Typhi
strains were cultured and maintained on Luria-Bertani (LB)
medium.
Motility Test
The motility tests were performed as previously described [6].
Briefly, bacteria were grown on LB agar, transferred with an
inoculation needle to the centre of an LB agar plate containing
0.3% agar and incubated for 24 hours at 37uC. The plates were
measured for the colony diameter at 6, 12, 18 and 24 hours. The
motility test was performed in triplicate.
Virulotyping
Five multiplex PCRs were used to amplify the 22 genes: agfA,
sefC and sefD [10]; cdtB, iroN, lpfC, pefA, prgH, sifA, sitC, sopB and
spvB [39]; misL, orfL, pipD, sopE and spiC [40]; invA [41]; mgtC
[42]; agfC [43]; spvC [44]; and lpfA [10]. These genes are involved
in adhesion, invasion, intracellular survival, systemic infection,
toxin production and Mg2+ and iron uptake. The amplification
was performed in a 25 ml reaction mixture that included 100 ng of
DNA template, 3 mM MgCl2, 0.75 U of Taq DNA Polymerase
(Promega Inc., Madison, WI, U.S.A.), 1X PCR buffer, 400 mM
dNTPs mix and 0.4 mM of each primer. The amplification was
carried out in a Mastercycler Gradient (Eppendorf, U.S.A.) with
the following cycling conditions: 95uC for 5 min, followed by 30
cycles of 94uC for 30 sec, 56.3uC for 30 sec, 72uC for 2 min, and a
final cycle of 72uC for 10 min.
Phenotypic Microarray
Theeight strains ofS.Typhiwereassayed for the carbonutilisation
on PhenotypeMicroarray (PM) (Biolog)microplates PM1 and PM2,
and the catabolism capacity of 190 different carbon substrates was
tested. The PM technology uses the irreversible reduction of
tetrazolium violet to formazan as a reporter of active metabolism
[16].The reductionof thedye causes the formationof apurple colour
that is recorded by a charge coupled-device camera every 15 min for
thedurationof the incubationperiod.Allprocedureswereperformed
as indicated by the manufacturer. First, S. Typhi isolates were
streaked on LB agar and incubated at 37uC for 18 hours. Five to ten
single colonies of each of the isolates were carefully picked up with a
Table 3. Carbon catabolic activity among Salmonella enterica serovar Typhi strains isolated from human blood, stool and sewage-
contaminated water.
Origin Strain
No. of carbon
substrates utilised Catabolism rate Catabolism activity*
Range Average
Standard
deviation
Blood{ ST191/05 51 24–173 96 35 4919
ST196/05 50 26–160 90 33 4503
ST33/06 52 31–141 79 27 4097
STVC3121 49 24–248 90 32 4418
Stool{ STC63/07 40 12–139 74 32 2940
ST280/90 43 3–138 56 33 2392
ST5680/07 51 28–155 74 33 3753
Sewage contaminated water STVC1681 51 15–151 88 31 4482
TOTAL 48 3–248 81 32 3938
*Catabolism activity =No. of carbon sources utilized6mean of catabolism rate.
{Catabolism activity between strains of blood origin and stool origin were significantly different at P-value of 0.013 (exclude the environmental strain VC1681) and 0.029
(include strain VC1681).
doi:10.1371/journal.pone.0036201.t003
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moistened cotton swab and resuspended in 15 ml of Biolog
inoculating fluid IF-0 until a cell density of 85% transmittance was
reached. Subsequently, 1% Biolog dye A (vol/vol) was added to the
cell suspension,and100 mlof themixturewas loadedintoeachwellon
PMmicroplatePM1andPM2.AllPMmicroplateswere incubatedat
37uCinanOmniLogreader, and the colour changes in thewellswere
monitored automatically every 15 min. The readings were recorded
for 24 hours, and the data were analysed using OminoLog PM
software,which generated a time course kinetic curve for tetrazolium
colour development. The option of A1 zero was selected during data
processing to deduct the background signal with reference to the A1
negative control well in each plate. Each strain was analysed in
duplicate, and the results were checked for consistency.
Statistical Analysis of PM Results
For each well, the averaged product of the average area under
the kinetic growth curve and the difference (Tmax–Tmin) of the
kinetic data obtained in duplicate experiments were used to assay
for positive growth under various PM conditions. The values of
average area under the kinetic growth curve for all negative wells
were analysed to obtain the background value so that a threshold
can be determined to offset the average area obtained for each of
the carbon substrates. A threshold value of 50 was set. The PM
conditions exceeding a threshold value of 50 were further screened
at the Tmax–Tmin value. Double screening for both the average
area and the differences ensured that only wells with an increasing
signal and a sufficient total area represent a positive growth
condition. The numerical values of the average area for positive
PM conditions were used for further analysis with BioNumerics
software (Applied Math, Kortrijk, Belgium).
For principal component analysis (PCA), the PM data were
filtered using the corrected average growth area as a parameter
and subsequently processed with BioNumerics software. For each
well, the average growth was corrected to zero if the difference was
less than the threshold value of 50. Clustering analysis was
performed to group the strains based on the metabolic diversity
with the simple matching similarity, and the clustering was based
on UPGMA.
Supporting Information
Table S1 Standardized value of the average area under the
kinetic growth curve (catabolic rate) for each of the fifty-two
carbon substrates catabolised by the S. Typhi strains.
(PDF)
Table S2 One-hundred and ninety various carbon sources
included in the carbon metabolic profiling of the eight S. Typhi
strains. Fifty-two substrates were utilized by the S. Typhi strains
tested while the others were not supportive of growth of S. Typhi.
(PDF)
Acknowledgments
We thank Adjunct Professor Dr. Niyaz Ahmed for proofreading the
manuscript and Professor Dr. Son Radu for the use of the Biolog
equipments.
The work was performed at Laboratory of Biomedical Science and
Molecular Microbiology, Institute of Graduate Studies, University of
Malaya.
Author Contributions
Conceived and designed the experiments: KLT LCC. Performed the
experiments: LCC KLT BHK OIE. Analyzed the data: LCC KLT.
Contributed reagents/materials/analysis tools: KLT. Wrote the paper:
KLT LCC.
References
1. Crump J, Mintz E (2010) Global trends in typhoid and paratyphoid fever. Clin
Infect Dis 50: 241–246.
2. Ismail A (2011) Early detection of cases and carriers of typhoid and other food
borne diseases. Malaysian J Pub Health Med 11: 4.
3. Parry CM, Hien TT, Dougan G (2002) Typhoid fever. N Engl J Med 347(22):
1770–1782.
4. Galanis ED M, Wong LF, Patrick ME, Binsztein N, Cieslik A, et al. (2006) Web-
based surveillance and global Salmonella distribution, 2000–2002. Emerg Infect
Dis. 12: 381–388.
5. Chang D-E, SmalleyDJ, Tucker DL, Leatham MP, Norris WE, et al. (2004)
Carbon nutrition of Escherichia coli in the mouse intestine. Proceeding of the Natl
Acad Sci USA 101: 7427–7432.
6. Eylert E, Scha¨r J, Mertins S, Stoll R, Bacher A, et al. (2008) Carbon metabolism
of Listeria monocytogenes growing inside macrophages. Mol Microbiol 69:
1008–1017.
7. Eisenreich W, Dandekar T, Heesemann J, Goebel W (2010) Carbon metabolism
of intracellular bacterial pathogens and possible links to virulence. Nature Rev
Microbiol 401–412.
8. Thong KL, Cordano AM, Yassin RM, Pang T (1996) Molecular analysis of
environmental and human isolates of Salmonella typhi. Appl Env Microbiol 62:
271–274.
9. Ba¨umler AJ, Gilde AJ, Tsolis RM, van der Velden AWM, Ahmer BM, et al.
(1997) Contribution of horizontal gene transfer and deletion events to the
development of distinctive patterns of fimbrial operons during evolution of
Salmonella serotypes. J Bacteriol 179: 317–322.
10. Ba¨umler AJ, Heffron F (1995) Identification and sequence analyses of
lpfABCDE, a fimbrial putative operon of Salmonella typhimurium. J Bacteriol
177: 2087–2097.
11. Gutnick D, Calvo JM, Klopotowski T, Ames BN (1969) Compounds which serve
as the sole source of carbon or nitrogen for Salmonella Typhimurium LT-2.
J Bacteriol 100: 215–219.
12. Sternfeld L, Saunders F (1938) The fermentation of mucic acid by some
interstina; bacteria. J Bacteriol 36: 53–56.
13. Sternfeld L, Saunders F (1937) The utilization of various sugars and their
derivatives by bacteria. Jour. Amer Chem Soc 59: 2653–2658.
14. Blanc-Potard AB, Groisman EA (1997) The Salmonella selC locus contains a
pathogenicity island mediating intramacrophage survival. Embo J 16:
5376–5385.
15. Retamal P, Castillo-Ruiz M, Mora GC (2009) Characterization of mgtC, a
virulent factor of Salmonella enterica serovar Typhi. PLoS ONE 4: e5551.
doi:10.1371/journal.pone.0005551.
16. Bochner BR, Gadzinski P, Panomitros E (2001) Phenotype microarrays for high-
throughput phenotypic testing and assay of gene function. Genome Res 11:
1246–1255.
17. Jensen KF, Nygaard P (1975) Purine-nucleoside phosphorylase from Escherichia
coli and Salmonella typhimurium: purification and some properties. Eur J Biochem
51: 253–265.
18. Hammer-Jespersen K (1983) Nucleoside catabolism. In Metabolism of
Nucleotides, Nucleosides and Nucleobases in Microorganisms, pp. 203-258.
Edited by A. Munch-Petersen. New York: Academic Press.
19. Simmonds RJ, Harkness RA (1981) High-performance liquid chromatographic
methods for base and nucleoside analysis in extracellular fluids and in cells.
J Chromatogr 226: 369–381.
20. Aguilo A, Castano E, Tauler P, Guix MP, Serra N, et al. (2000) Participation of
blood cells in the changes of blood amino acid concentrations during maximal
exercise. J Nutr Biochem 11: 81–86.
21. Samant S, Lee H, Ghassemi M, Chen J, Cook JL, et al. (2008) Nucleotide
biosynthesis Is critical for growth of bacteria in human blood. PLoS Pathog 4(2):
e37. doi:10.1371/journal.ppat.0040037.
22. Lin ECC (1977) Glycerol utilization and its regulation in mammals. Ann Rev
Biochem 46: 765–795.
23. Lundberg BE, Wolf RE, Dinauer MC, Xu Y, Fang FC (1999) Glucose-6-
phosphate dehydrogenase is required for Salmonella typhimurium virulence and
resistance to reactive oxygen and nitrogen intermediates. Infect Immun 67:
436–438.
24. Vazquez-Torres A, Jones-Carson J, Ba¨umler AJ, Falkow S, Valdivia R, et al.
(1999) Extraintestinal dissemination of Salmonella by CD18-expressing phago-
cytes. Nature 410: 804–808.
25. Richter-Dahlfors A, Buchan AM, Finlay BB (1997) Murine salmonelosis studied
by confocal microscopy: Salmonella typhimurium resides intracellularly inside
macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 186:
569–580.
Carbon Catabolism in Salmonella Typhi
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36201
26. Salcedo SP, Noursadeghi M, Cohen J, Holden DW (2001) Intracellular
replication of Salmonella typhimurium strains in specific subsets of splenic
macrophages in vivo. Cell Microbiol 3: 587–589.
27. Sheppard M, Webb C, Heath F, Mallows V, Emilianus R, et al. (2003)
Dynamics of bacterial growth and distribution within the liver during
Salmonella infection. Cell Microbiol 5: 593–600.
28. Monack DM, Mueller A, Falkow S (2004) Persistent bacterial infections: the
interface of the pathogen and the host immune system. Nat Rev Microbiol 2:
747–765.
29. Munoz-Elias E, McKinney JD (2006) Carbon metabolism of intracellular
bacteria. Cell Microbiol 8: 10–22.
30. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are
non-virulent and effective as live vaccines. Nature 291: 238–239.
31. Fields PI, Swanson RV, Haidaris CG, Heffron F (1986) Mutants of Salmonella
typhimurium that cannot survive within the macrophage are avirulent. Proc Natl
Acad Sci USA 83: 5189–5193.
32. McFarland WC, Stocker BA (1987) Effect of different purine auxotrophic
mutations on mouse-virulence of a Vi-positive strain of Salmonella Dublin and of
two strains of Salmonella typhimurium. Microb Pathog 3: 129–141.
33. O’Callaghan D, Maskell D, Liew FY, Easmon CS, Dougan G (1988)
Characterization f aromatic- and purine-dependent Salmonella typhimurium:
attenuation, persistence, and ability to induce protective immunity in BALB/c
mice. Infect Immun 56: 419–423.
34. Utley M, Franklin DP, Krogfelt KA, Laux DC, Cohen PS (1998) A Salmonella
typhimurium mutant unable to utilize fatty acids and citrate is avirulent and
immunogenic in mice. FEMS Microbiol Lett 163: 129–134.
35. Lawhon SD, Maurer R, Suyemoto M, Altier C (2002) Intestinal short-chain fatty
acids alter Salmonella typhimurium invasion gene expression and virulence through
BarA/sirA. Mol Microbiol 46: 1451–1464.
36. Horswill AR, Dudding AR, Escalante-Semerena JC (2001) Studies of propionate
toxicity in Salmonella enterica identify 2-methylcitrate as a potent inhibitor of cell
growth. J Biol Chem 276: 19094–19101.
37. Brock M, Buckel W (2004) On the mechanism of action of the antifungal agent
propionate. Eur J Biochem 271: 3227–3241.
38. Thong KL, Cheong YM, Puthucheary S, Koh CL, Pang T (1994)
Epidemiologic analysis of sporadic Salmonella typhi isolates and those from
outbreaks by pulsed-field gel electrophoresis. J Clin Microbiol 32: 1135–1141.
39. Skyberg J, Logue C, Nolan L (2006) Virulence genotyping of Salmonella spp. with
multiplex PCR. Avian Dis 50: 77–81.
40. Hughes L, Shopland S, Wigley P, Bradon H, Leatherbarrow A, et al. (2008)
Characterization of Salmonella enterica serotype Typhimurium isolates from wild
birds in northern England from 2005–2006. BMC Vet Res 4: 4.
41. Rahn K, De Grandis S, Clarke R, Mcewen S, Gala´n J, et al. (1992)
Amplification of an invA gene sequence of Salmonella typhimurium by polymerase
chain reaction as a specific method of detection of Salmonella. Mol Cell Probes 6:
271–279.
42. Soto SM, Rodriguez I, Rodicio MR, Vila J, Mendoza MC (2006) Detection of
virulence determinants in clinical strains of Salmonella enterica serovar Enteritidis
and mapping on macro restriction profiles. J Med Microbiol 55: 365–373.
43. Gibson DL, White AP, Rajotte CM, Kay WW (2007) AgfC and AgfE facilitate
extracellular thin aggregative fimbriae synthesis in Salmonella Enteritidis.
Microbiol 153: 1131–1140.
44. Chiu CH, Ou JT (1996) Rapid identification of Salmonella serovars in feces by
specific detection of virulence genes, invA and spvC, by an enrichment broth
culture-multiplex PCR combination assay. J Clin Microbiol 34: 2619–2622.
Carbon Catabolism in Salmonella Typhi
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36201
